Xinhua News Agency, Beijing, February 26th: Medlander released its 2024 earnings report. During the reporting period, the company's total operating revenue reached 423 million yuan, representing a year-on-year increase of 24.02%; operating profit amounted to 113 million yuan, up 10.06% year-on-year; total profit reached 123 million yuan, marking a year-on-year growth of 21.66%; net profit attributable to the parent company’s owners was 102 million yuan, increasing by 13.75% year-on-year; net profit attributable to the parent company’s owners after deducting non-recurring gains and losses stood at 90.4377 million yuan, surging 26.42% year-on-year. The main factors affecting operating performance were the company's strengthened brand building, optimized sales channels, and rapid growth in sales of reproductive rehabilitation products, consumables, and accessories.
Proofread by Yang Xuli